Latest stories on PALI
Palisade Bio to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Palisade Bio to Participate in Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Palisade Bio Reports Q2 Eps 22c Consensus 5c
The Fly73 · bullishearnings
Palisade Bio GAAP EPS of -$0.05 in-line, revenue of $0.5M
Seeking Alpha47 · neutralearnings
Palisade Bio Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of PALI-2108 Into Phase 2 Development
Business Insider56 · neutralproduct/pr
PALISADE BIO, INC. (PALI) files 8-K
SEC 8-K50 · neutralgeneral
Palisade Bio Draws Bullish Call, Lead IBD Drug Advances Toward Phase 2
Yahoo Top63 · neutralanalyst
Palisade Bio jumps following Oppenheimer outperform initiation
Seeking Alpha63 · neutralanalyst
Palisade's Dan Veru talks his small cap trading playbook
CNBC50 · neutralgeneral
Palisade Bio to Participate in the Leerink Partners Therapeutics Forum
Business Insider56 · neutralgeneral
Palisade Bio to Participate in the Leerink Partners Therapeutics Forum | PALI Stock News
StockTitan63 · neutralproduct/pr
Palisade Bio: A Unique MoA Targeting The UC And Crohn's Disease Markets
Seeking Alpha63 · neutralproduct/pr
PALI Stock Heads For Best Day In Seven Months – What’s Driving Today’s Rally?
Stocktwits News73 · bullishproduct/pr
Palisade Bio Shares Rise After FDA Clears PALI-2108 for Phase 2 Trial
Morningstar67 · bullishproduct/pr
PALISADE BIO, INC. (PALI) files 8-K
SEC 8-K50 · neutralgeneral
Palisade Bio to Participate in the Jefferies Global Healthcare Conference | PALI Stock News
StockTitan55 · neutralgeneral
Palisade Bio (PALI) Reports Q1 2026 Results as R&D Expenses Rise to $6.4M
Yahoo Top48 · neutralearnings